Phase I Study of HLX3 vs Adalimumab in Chinese Healthy Subjects
Clinical trial NCT03357939 · COMPLETED
Trial details
- NCT number
- NCT03357939
- Sponsor
- Shanghai Henlius Biotech
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-12
- Primary completion
- 2018-09-15
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.